SCOLR PHARMA, INC.
CIK 0000934936
Revenue (TTM)
$367K
Q3 Nov 2011
Net Income (TTM)
−$2.74M
Q3 Nov 2011
EPS Diluted (TTM)
—
Q3 Nov 2011
Gross Margin
—
Q3 Nov 2011
Operating Margin
-733.0%
Q3 Nov 2011
Net Margin
-745.8%
Q3 Nov 2011
Free Cash Flow (TTM)
—
Q3 Nov 2011
Cash
$645K
Q3 Nov 2011
Total Debt
—
Q3 Nov 2011
Shares Outstanding
49.82M sh
Q3 Nov 2011